Course: DETECT T1D: From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
CME Credits: 0.00
Released: 2025-10-15
This interactive TeleECHO series aims to help clinicians diagnose patients with early-stage type 1 diabetes (T1D) by screening for the presence of islet autoantibodies (IAbs) as well as identify patients with Stage 2 T1D eligible for treatment with the disease-modifying therapy, teplizumab, which is approved to delay progression to Stage 3 T1D. Real-world case examples and discussions are included to highlight various patient-specific characteristics that influence clinical recommendations related to screening and treatment.
		  
			             Upon completion of this activity, participants should be better able to:          
View Full Course